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m: Continuous work in the field of Retinal Transplantation 
baa now been carried out for more than a decade. we are at the stage 
where cIinicaI studies are underway. With this work, we plan on 
investigating the clinical and functional outcomes of fetal neural 
Mind cells transplanted to patients with Retinitis Pigmentosa (RP). 
M&Q&: Dissociated neural retinal cells from 14 to 16 week old 
human fetuses were injected into the subretinal space of three 
patients with RP. Prior to surgery, the visual acuity was limited to 
light perception, and the ERGS were subnormal in both eyes of all 
patients. This work was carried out in strict accordance with Federal 
and Iustitutio”al guidermea. 
m: At three months pest-transplantation, there was.no 
t’eiection cliicallv. and no comelications had occurred. The arafts 
@ 
p”. 
ared clinical& to be stable’ with no sign of inflammati& 01 
in ectuxt. Up to this point, there was no subjective visual 
improvement. The patients are being followed closely via many 
pammtcm including ERGS. 
cwfhuiona: This initial clinical series shows that no undesirable 
side effects occurred in retinis pigmentosa patients as a result of 
subretinal eraftine. even in the absence of svstcmic 
immunosup&i~n. ,&this phase. it appears that the tm&mb~ 
lias no deleterious effects. Ongoing shxiies will indicate if, and 
under what circumstances, visual recovery may take place. 
s140 
